Biosimilar transition policies are paving the way for new, innovative arthritis treatments. Learn about biosimilar safety and efficacy and discover research that our scientists are doing to address patient concerns.
Educational grants-in-aid provided by:
Subscribe to The Arthritis Newsletter
Sign up and receive news and updates on arthritis research aimed at arthritis prevention, early diagnosis, new and better treatment, and improved quality of life.